Biotech/Healthcare - Baltimore, MD, US
NeoProgen, Inc., a pre-clinical stage company developing an exosome-based product from human neonatal heart-derived Medicinal Signaling Cells (nMSCs) for tissue repair and regeneration for the treatment of heart failure (HF) and other inflammatory diseases.
Outlook
GoDaddy Hosting
Mobile Friendly